Current and Past Funding
RESEARCH SUPPORT
NCI PREVENT TORFP 2023 12/1/23-11/30/26
Application PI
Targeting the A2B adenosine receptor for immunoprevention of pancreatic cancer
Multi PI: McAllister
The goal of this NCI contract is to study two orally bioavailable A2BR small molecule inhibitors in PDAC GEM models to assess clinical potential for immunoprevention.
R01CA277161_01A1 07/01/2023-06/30/2028
Bailey (PI) | Thosani (MPI)
A single-arm phase II study to evaluate the safety and efficacy of combination systemic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer
NCI PREVENT TORFP 2020 E-10 (Bailey) 09/15/20-12/20/23
Preclinical testing of CD73 inhibitors for pancreatic cancer immunoprevention
Role: Application PI
Multi PI: McAllister, Brown
The goal of this NCI contract is to study two orally bioavailable compounds in PDAC GEM models to assess clinical potential for immunoprevention.
1R21CA249924-01 (Bailey) 01/2021-12/2023 NCI/NIH
Defining the role of Mst1/Mst2 in regulating metabolic alterations in Ras driven NSCLC
Role: PI
Multi PI: Ying
NIH/P30DK056338-18
Texas Digestive Disease Center Pilot Award 01/2021- 12/2021
Adenosine Signaling in Pancreatitis associated with pancreatic ductal obstruction initiated by mutant Kras
Role: PI
COMPLETED GRANT SUPPORT
Plexxicon Contract 06/30/21-06/30/22
Testing CD73i oral gavage inhibitors for immunotherapy in pancreatic cancer.
Role: PI
Pilot Grant 07/2021-06/2022
Center for Perioperative Medicine
Defining the role of a Hif2a/MiR-29 axis in T cell inflammation in inflammatory bowel disease
Role: PI
Pilot Grant 07/2018- 07/2019
McGovern Medical School
Title: A functional genomics approach to define driver mutations in pancreatic cancer
Role: PI
Research Grant 06/2017-06/2018
National Pancreas Foundation
Title: Can high Ras activity transform pancreatic ductal cells?
Role: PI
P30DK056338-18 03/2015-07/2016
Texas Digestive Disease Center Pilot Award
Title: Critical Mechanisms underlying pancreatic regeneration: a new role for p120 catenin
Role: PI
AACR-PANCAN Pathway to Leadership Award (K99/R00 Like Grant) 07/2011-08/2017
American Association for Cancer Research and The Pancreatic Cancer Action Network Title: Stop the Start: Novel Insights into PanIN Initiation and Progression
Role: PI
NIH T35 DK007676-22 Kone (PI) 05/2017-08/2017
($106,000)/annually
Title: Aldh1a1: Hypoxic regulation of sphingosine signaling in pancreatic cancer
Role: Faculty Mentor; Student: Gary Chen
NIH T35 DK007676-22 Kone (PI) 05/2016-08/2016
($106,000)/annually
Title: Aldh1a1: Friend or Foe in pancreatic regeneration and pancreatitis?
Role: Faculty Mentor; Student: Logan Oliver
NIH T35 DK007676-22 Kone (PI) 05/2016-08/2016
($106,000)/annually
Title: Defining a Stellate Cell Axis in Liver Disease and HCC
Role: Faculty Mentor; Student: Eric Yoon
NIH T35 DK007676-22 Kone (PI) 05/2015-08/2015
($106,000)/annually
Title: p120 catenin is required for regeneration of the exocrine pancreas in mice
Role: Faculty Mentor; Student: Neal Jones
1F32 CA157044-01 07/2011-06/2014
National Institutes of Health-National Cancer Institute Ruth L. Kirschstein National Research Service Awards for Individual Postdoctoral Fellows (F32)
Title: Stopping the Start: Understanding PanIN Initiation and Progression
Role: PI
Graduate Student Fellowship 06/2006-06/2009
The Eppley Institute, University of Nebraska Medical Center
Title: Sonic Hedgehog Paracrine Signaling Promotes Metastasis and Lymphangiogenesis in Pancreatic Cancer
Role: PI
NIH Cancer Biology Training Grant (T32) 06/2005-06/2006
Eppley Institute, University of Nebraska Medical Center
Title: Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
Role: Trainee